Mr. Chair, it's one of the rationales for the existence of laboratories that you have a safe place to bring in any clinical material when a new disease is emerging. When the safety profile at the early outset is unknown, you can put it into a category 4 or category 3 lab as you see fit, and do the work to characterize it and understand the nature of that emerging organism.
It is one of the key rationales for having a laboratory like the NML in Canada.